Table 1 Clinical characteristics of enrolled patients
From: Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
Patient characteristics | Overall (n) | Percentage (%) |
|---|---|---|
Age (years) | ||
 ≤ 40 | 41 | 20.4 |
 41–60 | 72 | 35.8 |
 61–75 | 78 | 38.8 |
 > 75 | 10 | 5.0 |
Gender | ||
 Male | 112 | 55.7 |
 Female | 89 | 44.3 |
LDH ratio | Â | Â |
 ≤ 1 | 118 | 58.7 |
 2–3 | 74 | 36.8 |
 > 3 | 9 | 4.5 |
β2-MG ratio | ||
 ≤ 1 | 138 | 68.7 |
 > 1 | 63 | 31.3 |
Ann Arbor stage | ||
 I–II | 77 | 38.3 |
 III–IV | 124 | 61.7 |
ECOG PS | ||
 < 2 | 145 | 72.1 |
 ≥ 2 | 56 | 27.9 |
Involvement of extranodal important organs | ||
 Yes | 86 | 42.8 |
 No | 115 | 57.2 |
B symptoms | ||
 Yes | 69 | 34.3 |
 No | 132 | 65.7 |
Pathological type | ||
 GCB | 77 | 38.3 |
 Non-GCB | 124 | 61.7 |
PET/CT scanner | ||
 PHILIPS GEMINI GXL16 | 93 | 46.3 |
 PHILIPS Vereos | 108 | 53.7 |